FDA reschedules Xigris meeting

FDA rescheduled for Oct. 16 an advisory committee meeting for Xigris

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE